SBRT Combined With Chemotherapy and Tislelizumab in Metastatic NPC
SBRT Combined With Chemotherapy and Tislelizumab in Metastatic NPC
Recruiting · NCT05652192 · Registry updated 2022-12-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| SBRT Combined With Chemotherapy and Tislelizumab in Metastatic NPC | Advanced Nasopharyngeal Carcinoma | Recruiting | Phase 2 | 2022-12-15 | NCT05652192 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Zhejiang Cancer Hospital | 142 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Zhejiang Cancer Hospital | Hangzhou | China | 164 |